 SC Guidelines for Diabetes Care 2011. Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.

Slides:

Advertisements

Similar presentations

ADA Criteria for the diagnosis of diabetes Table 3—Criteria for the diagnosis of diabetes 1. A1C ≥ 6.5%. The test should be performed in a laboratory.

Advertisements

Diagnosis of Type 2 Diabetes 1. Glucose Testing and Interpretation: AACE Diagnostic Criteria TestResultDiagnosis FPG, mg/dL (measured after 8-hour fast)

Diabetes in Pregnancy Screening.

Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.

Stanford GEC Copyright © 2005 Mental Health Aspects of Diabetes in Elders from Diverse Ethnic Backgrounds Prepared by: Jill LeCount, RN, MS, CNS Based.

Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects Core Elements Update July 28,

Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.

Diabetes Prevention Group Screening and Eligibility Core Elements Update May 2005.

A medical test to determine the ability of an individual to maintain HOMEOSTASIS of Blood Glucose The most commonly performed version of the Test (OGTT)

Diagnosis of Type 2 Diabetes 1. Diagnostic Criteria for Prediabetes and Diabetes in Nonpregnant Adults 2 NormalHigh Risk for DiabetesDiabetes FPG

Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.

DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.

O Identify whether all patients in the practice population diagnosed with IFG have had a repeat fasting blood glucose (FBG) within the past 12months o.

Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?

Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(

Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A double-tracer study.

ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.

Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.

Diagnosis Glucose tolerance is classified into three broad categories: normal glucose homeostasis, diabetes mellitus, and impaired glucose homeostasis.

Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.

©1999, Medical Age Publishing, Division of Snyder Healthcare Communications Worldwide, Stamford, Connecticut. All rights reserved. Epidemiology and Diagnosis.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.

1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea A.

Contributions to Type 2 Diabetes. Glucose in balance meal Time in minutes Blood glucose levels, mg/dL Insulin levels, uU/mL Glucagon.

Background notes Audience: diabetes professional (entry level), patients with diabetes First slide: ADD your name/institution ‘Sponge bob’ slide: hemoglobin.

1 INTRODUCTION Nearly 25% of diabetes patients use insulin Many practitioners: –Are uncomfortable with insulin dosing –Base dosing decisions on empiric.

Measures of Hyperglycemia Random plasma glucose (RPG)—without regard to time of last meal Fasting plasma glucose (FPG)—before breakfast Oral glucose tolerance.

A two stage screening process – the pre-diabetes pathway.

Glycemia Treatment Strategies Used In ACCORD

Prevention, Management and Diagnosis of Diabetes in Primary Care

Screening System for Hypertension and Diabetes at Primary Care Level

Addressing Undiagnosed Cases of Diabetes in Asian Americans

DIP, GDM; CLINICAL IMPORTANCE AND NEW WHO DIAGNOSTIC CRITERIA FOR GDM

Screening for Diabetes in Pregnancy

A Study on Gestational Diabetes in Eastern India

Copyright © 2017 American Academy of Pediatrics.

Copyright © 2011 American Medical Association. All rights reserved.

WHAT IS THE REAL NORMAL RANGE?

Because we would like to optimally individualize patient care, n-of-1 randomized clinical trials are at the top of the hierarchy of study designs, followed.

Copyright © 2015 by the American Osteopathic Association.

Copyright © 2015 by the American Osteopathic Association.

Diabetes and Pregnancy

W.S.T. Swarnasri1, Noel P. Somasundaram2

D2d participating clinical sites

Screening for Diabetes in Pregnancy

Prevention, Management and Diagnosis of Diabetes in Primary Care

Athena Philis-Tsimikas, MD The American Journal of Medicine

دیابت سالمندان دکتر میترا مرادی نیا.

Reducing the Risk of Developing Diabetes

A randomized controlled trial of a web-based education intervention for women with gestational diabetes mellitus Mary Carolan-Olah, Padaphet Sayakhot

Part 1 This slide reviews criteria for diabetes diagnosis from the 2015 ADA guidelines. Refer to source document for full recommendations, including level.

Receiver operating characteristic analyses showing area under the curves with reference to 2-hour OGTT (A,B) and fasting plasma glucose (C,D). HbA1c, glycated.

ROGER S. MAZZE, Ph.D., CHRISTOPHER L. KROGH, M.D.

Part 3 This slide reviews recommendations for the frequency of A1C testing from the 2015 ADA guidelines. Refer to source document for full recommendations,

Disorders Associated with Insulin and Glucagon

Volume 368, Issue 9541, Pages (September 2006)

Schematic of screening program for diabetes mellitus (DM) during acute myocardial infarction (AMI). Schematic of screening program for diabetes mellitus.

Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6

Mean decline in grip strength with aging by baseline quartile of fasting plasma glucose (FPG). Mean decline in grip strength with aging by baseline quartile.

Glucose tolerance in WT and TRPM2-KO mice.

Stratified analysis of the association between GDM and abdominal circumference (AC) >90th percentile at 28 wkGA. Stratified analysis of the association.

Yield of abnormal glucose tolerance in 30,383 people screened by the DPP who underwent OGTT by sex, age, BMI, family history of diabetes, and ethnicity.

(A) Oral glucose tolerance test (OGTT) glucose and (C) natural logarithm of insulin responses over time with SEM bars comparing the first tertile to the.

Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.

Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6

Incidence of DM as a function of TyG index (white bars) or TG/HDL-C ratio (black bars). Incidence of DM as a function of TyG index (white bars) or TG/HDL-C.

Doses of trial medication in the liraglutide groups (A) and in the placebo groups (B). Doses of trial medication in the liraglutide groups (A) and in the.

Glycemic control in Hispanic and non-Hispanic patients during the SWITCH 2 trial. Glycemic control in Hispanic and non-Hispanic patients during the SWITCH.

Presentation transcript:

 SC Guidelines for Diabetes Care 2011

Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting Plasma Glucose (FPG), or 2-h 75-g Oral Glucose ToleranceTest (OGTT) are appropriate. An A1C level of 5.7% to 6.4% indicates increased risk for diabetes. The presence of diabetes is indicated by:  A1C level of 6.5 % or higher;  FPG level of > 126 mg/dl;  OGTT level > 200 mg/dl. Reference: American Diabetes Association. Standards of Medical Care in Diabetes Diabetes Care. Volume 34, Supplement 1. January

 SC Guidelines for Care of Persons with Diabetes 2011

South Carolina Guidelines for Diabetes Care 2011

Level of evidence for most significant recommendations: A = Randomized Clinical Trial B = Controlled trials, no randomization C = Observational studies D = Opinion of expert panel E = Expert or clinical opinion

Approved by Diabetes Initiative of South Carolina September 2, 2011